24th Sep 2021

Vaccine export 'ban' row heats up ahead of EU summit

  • British prime minister Boris Johnson and EU Commission chief Ursula von der Leyen in Brussels. The vaccine row and the trade dispute over Northern Ireland have put the fragile post-Brexit UK-EU relationship under further pressure (Photo: European Commission)

British prime minister Boris Johnson hit a conciliatory tone on Monday (22 March) in the vaccine-export row between the UK and the EU - ahead of a meeting of EU leaders later this week.

Johnson said that the EU does not want to launch a vaccine battle, adding that avoiding blockages of vaccine supplies is key for countries working together on immunisation, Bloomberg reported.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

EU Commission president Ursula von der Leyen last week warned that the bloc could restrict vaccine exports to the UK, as the EU executive aims to make sure the pharmaceutical company AstraZeneca delivers the doses pledged to the EU.

"I'm reassured by talking to EU partners over the last few months that they don't want to see blockades," Johnson said in comments as the export ban debate flared up over the weekend.

The vaccine row and trade disputes over Northern Ireland have put the fragile post-Brexit UK-EU relationship under increased pressure.

The British premier has been in contact with Dutch prime minister Mark Rutte and Belgian PM Alexander De Croo ahead of the online-only EU summit later this week, where leaders are expected to discuss the broader export ban.

"We are all facing the same pandemic, we all have the same problems," Johnson said.

The commission's dispute is primarily with AstraZeneca. Von der Leyen said at the weekend that the firm had delivered only 30 percent of the 90 million vaccine doses it had promised for the first quarter of 2020.

"We have the option of banning a planned export. That's the message to AstraZeneca: you fulfil your contract with Europe first before you start delivering to other countries," she told Germany's Funke media group.

The company has blamed production delays at its European plants - but it has been able to deliver doses under its UK contract.

The current row centres around a stockpile of the Astra vaccine's active ingredient produced in the Netherlands by subcontractor, Halix.

The factory does not yet have regulatory approval to supply to the EU, but is expected to receive it soon from the European Medicines Agency (EMA).

It is named as a supplier of vaccines in both the contracts that AstraZeneca has signed with Britain and with the EU.

"This is not about banning vaccine exports, this is about making sure that companies deliver on their commitments to the member states and the EU that are inscribed in contracts," commission spokesman Eric Mamer said.

He added that exports from companies that manufacture doses in the EU is "in itself is good a thing".

"We want to see reciprocity and proportionality in these exports," Mamer said.

According to current EU rules, the national authority notifies the commission once a vaccine producer wants to export. In case the commission and the national authority do not agree on whether to allow the export, the college of commissioners takes a decision.

All companies have introduced requests, but so far the ban was used only once - by the EU and Italy - in the case of AstraZeneca wanting to export from Italy to Australia.

The UK is the largest recipient of doses made in the EU, receiving 10 million of 41 million shots exported by the bloc, von der Leyen said last week. There have been no vaccine exports to the EU from the UK.

Ireland's prime minister, Micheál Martin, told RTE radio he is opposed to the suggestion that the EU could impose an export ban on vaccines going specifically to the UK, describing it as a "retrograde step".

EU to control vaccine exports in row over delays

The European Commission wants to control exports of coronavirus vaccines to outside the bloc, after pharmaceutical firms said EU countries will receive fewer jabs than they ordered due to alleged production problems.

EU sharpens vaccine export tool, amid third wave

The UK seems to be targeted as it has received 10m vaccines since January from the EU but has not exported back. Several EU countries are cautious about the tighter curbs fearing it could harm global supply chains.

EU missed March vaccination target for priority groups

The EU failed to reach its target of having at least 80 percent of the elderly and healthcare workers vaccinated by the end of March. According to estimates, 55 percent will be vaccinated by the end of June.

EU medicines agency: booster shots not urgent

The European Medicines Agency said that there is no urgent need to administer booster shots to the general population, pointing out that the priority now should be to vaccinate the one-third of Europeans who are not fully vaccinated.

Stakeholders' Highlights

  1. Nordic Council of MinistersNATO Secretary General guest at the Session of the Nordic Council
  2. Nordic Council of MinistersCan you love whoever you want in care homes?
  3. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  4. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals
  5. Nordic Council of MinistersNordic Council enters into formal relations with European Parliament
  6. Nordic Council of MinistersWomen more active in violent extremist circles than first assumed

Latest News

  1. Activists: 'More deaths' expected on Polish-Belarus border
  2. EU unveils common charger plan - forcing Apple redesign
  3. Central Europe leaders rail against 'new liberal woke virus'
  4. Yemen's refugees in 'appalling conditions', says UN agency
  5. VW emissions software was illegal, top EU lawyer says
  6. Sexism and the selection of the European Parliament president
  7. More French names linked to Russia election-monitoring
  8. Negotiations set for new, tougher, EU ethics body

Join EUobserver

Support quality EU news

Join us